Literature DB >> 32592691

Protein Kinase C Theta Modulates PCMT1 through hnRNPL to Regulate FOXP3 Stability in Regulatory T Cells.

E Ilker Ozay1, Sudarvili Shanthalingam2, Joe A Torres1, Barbara A Osborne3, Gregory N Tew4, Lisa M Minter5.   

Abstract

T cell receptor signaling, together with cytokine-induced signals, can differentially regulate RNA processing to influence T helper versus regulatory T cell fate. Protein kinase C family members have been shown to function in alternative splicing and RNA processing in various cell types. T cell-specific protein kinase C theta, a molecular regulator of T cell receptor downstream signaling, has been shown to phosphorylate splicing factors and affect post-transcriptional control of T cell gene expression. In this study, we explored how using a synthetic cell-penetrating peptide mimic for intracellular anti-protein kinase C theta delivery fine-tunes differentiation of induced regulatory T cells through its differential effects on RNA processing. We identified protein kinase C theta signaling as a critical modulator of two key RNA regulatory factors, heterogeneous nuclear ribonucleoprotein L (hnRNPL) and protein-l-isoaspartate O-methyltransferase-1 (PCMT1), and loss of protein kinase C theta function initiated a "switch" in post-transcriptional organization in induced regulatory T cells. More interestingly, we discovered that protein-l-isoaspartate O- methyltransferase-1 acts as an instability factor in induced regulatory T cells, by methylating the forkhead box P3 (FOXP3) promoter. Targeting protein-l-isoaspartate O-methyltransferase-1 using a cell-penetrating antibody revealed an efficient means of modulating RNA processing to confer a stable regulatory T cell phenotype.
Copyright © 2020 The American Society of Gene and Cell Therapy. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  FOXP3; PCMT1; PKCθ; alternative splicing; cell-penetrating peptide mimics; hnRNPL; induced regulatory T cell; intracellular antibody delivery

Year:  2020        PMID: 32592691      PMCID: PMC7544975          DOI: 10.1016/j.ymthe.2020.06.012

Source DB:  PubMed          Journal:  Mol Ther        ISSN: 1525-0016            Impact factor:   11.454


  85 in total

1.  A conserved signal-responsive sequence mediates activation-induced alternative splicing of CD45.

Authors:  Caryn Rothrock; Brian Cannon; Brandon Hahm; Kristen W Lynch
Journal:  Mol Cell       Date:  2003-11       Impact factor: 17.970

Review 2.  Understanding alternative splicing: towards a cellular code.

Authors:  Arianne J Matlin; Francis Clark; Christopher W J Smith
Journal:  Nat Rev Mol Cell Biol       Date:  2005-05       Impact factor: 94.444

Review 3.  Alternative splicing: a pivotal step between eukaryotic transcription and translation.

Authors:  Alberto R Kornblihtt; Ignacio E Schor; Mariano Alló; Gwendal Dujardin; Ezequiel Petrillo; Manuel J Muñoz
Journal:  Nat Rev Mol Cell Biol       Date:  2013-02-06       Impact factor: 94.444

Review 4.  How regulatory T cells work.

Authors:  Dario A A Vignali; Lauren W Collison; Creg J Workman
Journal:  Nat Rev Immunol       Date:  2008-07       Impact factor: 53.106

5.  HnRNP L stimulates splicing of the eNOS gene by binding to variable-length CA repeats.

Authors:  Jingyi Hui; Karl Stangl; William S Lane; Albrecht Bindereif
Journal:  Nat Struct Biol       Date:  2003-01

6.  IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.

Authors:  Christian Koenecke; Chun-Wei Lee; Kristina Thamm; Lisa Föhse; Matthias Schafferus; Hans-Willi Mittrücker; Stefan Floess; Jochen Huehn; Arnold Ganser; Reinhold Förster; Immo Prinz
Journal:  J Immunol       Date:  2012-08-06       Impact factor: 5.422

7.  A compendium of RNA-binding motifs for decoding gene regulation.

Authors:  Debashish Ray; Hilal Kazan; Kate B Cook; Matthew T Weirauch; Hamed S Najafabadi; Xiao Li; Serge Gueroussov; Mihai Albu; Hong Zheng; Ally Yang; Hong Na; Manuel Irimia; Leah H Matzat; Ryan K Dale; Sarah A Smith; Christopher A Yarosh; Seth M Kelly; Behnam Nabet; Desirea Mecenas; Weimin Li; Rakesh S Laishram; Mei Qiao; Howard D Lipshitz; Fabio Piano; Anita H Corbett; Russ P Carstens; Brendan J Frey; Richard A Anderson; Kristen W Lynch; Luiz O F Penalva; Elissa P Lei; Andrew G Fraser; Benjamin J Blencowe; Quaid D Morris; Timothy R Hughes
Journal:  Nature       Date:  2013-07-11       Impact factor: 49.962

8.  Arginine/serine-rich domains of SR proteins can function as activators of pre-mRNA splicing.

Authors:  B R Graveley; T Maniatis
Journal:  Mol Cell       Date:  1998-04       Impact factor: 17.970

9.  HnRNP L and L-like cooperate in multiple-exon regulation of CD45 alternative splicing.

Authors:  Marco Preussner; Silke Schreiner; Lee-Hsueh Hung; Martina Porstner; Hans-Martin Jäck; Vladimir Benes; Gunnar Rätsch; Albrecht Bindereif
Journal:  Nucleic Acids Res       Date:  2012-03-08       Impact factor: 16.971

10.  Alternative splicing of MALT1 controls signalling and activation of CD4(+) T cells.

Authors:  Isabel Meininger; Richard A Griesbach; Desheng Hu; Torben Gehring; Thomas Seeholzer; Arianna Bertossi; Jan Kranich; Andrea Oeckinghaus; Andrea C Eitelhuber; Ute Greczmiel; Andreas Gewies; Marc Schmidt-Supprian; Jürgen Ruland; Thomas Brocker; Vigo Heissmeyer; Florian Heyd; Daniel Krappmann
Journal:  Nat Commun       Date:  2016-04-12       Impact factor: 14.919

View more
  1 in total

1.  PCMT1 Is a Potential Prognostic Biomarker and Is Correlated with Immune Infiltrates in Breast Cancer.

Authors:  Jufang Guo; Xuelian Du; Chaolin Li
Journal:  Biomed Res Int       Date:  2022-04-30       Impact factor: 3.246

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.